Table 2.
Changes in clinical parameters at week 2, 4 and 8 (median (25%, 75%)).
| Parameters | Control Group (n = 6) | HW Group (n = 7) |
|---|---|---|
| PPD (mm) | ||
| Week 2 | 0.12 (0.08, 0.20) * | −0.10 (−0.31, −0.01) ‡ |
| Week 4 | 0.12 (0.07, 0.18) | −0.28 (−0.49, −0.02) †,‡ |
| Week 8 | 0.01 (−0.05, 0.14) | −0.34 (−0.52, −0.11) †,‡ |
| CAL (mm) | ||
| Week 2 | 0.12 (0.08, 0.20) | −0.10 (−0.31, −0.01) ‡ |
| Week 4 | 0.12 (0.07, 0.18) | −0.28 (−0.49, −0.02) †,‡ |
| Week 8 | 0.01 (−0.05, 0.14) | −0.34 (−0.52, −0.11) †,‡ |
| BOP (%) | ||
| Week 2 | 0.00 (−5.06, 5.08) | −2.39 (−13.01, 2.38) |
| Week 4 | 1.79 (−14.14, 3.89) | −11.90 (−24.31, 2.38) † |
| Week 8 | 0.01 (−15.18, 2.67) | −5.96 (−24.41, −0.60) † |
| PI | ||
| Week 2 | 0.00 (−0.04, 0.07) | 0.07 (−0.13, 0.46) |
| Week 4 | −0.02 (−0.19, 0.25) | −0.17 (−0.65, 0.00) † |
| Week 8 | 0.09 (−0.07, 0.13) | −0.03 (−0.72, 0.25) |
* Differences (each time point minus baseline); † p < 0.05, compared with the baseline, using Wilcoxon signed-rank test. ‡ p < 0.05, compared with the control group, using Mann-Whitney U test.